Fabulous支架系统治疗复杂型B型主动脉夹层五年结果:前瞻性多中心研究
该前瞻性单臂多中心研究纳入中国14中心144例复杂型Stanford B型主动脉夹层患者,评估Fabulous支架系统五年疗效。五年全因死亡免除率为86.6%,影像随访显示真腔最小直径持续增加、裸支架段假腔最大直径持续缩小,假腔完全血栓化比例从64%升至81%。
要点
- Fabulous支架系统治疗cTBAD五年全因死亡免除率86.6%。
- 裸支架段假腔完全血栓化比例从64%升至81%。
- 五年随访中3例发生逆行A型夹层,3例接受二次干预。
核心结论
- Fabulous支架系统腔内治疗cTBAD五年随访显示真腔扩张和假腔血栓化结果令人鼓舞。
研究设计与样本
- 主要结局为全因死亡免除率和长期主动脉相关不良事件免除率。
主要发现
- 五年全因死亡免除率为86.6%。
- 影像随访完成64例(平均年龄54.4岁,男性89.1%)。
- 真腔最小直径从术前13.01±6.52 mm增至五年24.68±5.27 mm,裸支架段假腔最大直径从28.69±7.09 mm降至7.67±12.51 mm。
- 裸支架段假腔完全血栓化比例从64%升至81%。
- 五年随访中3例发生逆行A型夹层,3例接受二次干预。
临床怎么用
- Fabulous支架系统可用于cTBAD的腔内治疗,五年随访支持真腔扩张和假腔血栓化。
- 结果有助于理解PETTICOAT技术在cTBAD中的应用。
局限性
- 单臂研究,无对照组。
- 五年影像随访仅完成64例,样本量有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: This study aimed to assess the five year follow up results from a prospective, single arm, multicentre study evaluating the efficacy of the Fabulous stent system (DiNovA Meditech, Hangzhou, China) in the treatment of complicated Stanford type B aortic dissection (cTBAD). METHODS: Between December 2017 and October 2019, 144 patients from 14 centres in China were prospectively enrolled. Primary outcomes were freedom from all cause death and long term aortic related adverse events. Secondary five year outcomes were the changes in the false lumen (FL) and true lumen (TL) in the bare stent and distal bare stent segments. RESULTS: The five year freedom from all cause death was 86.6%, and imaging follow up was completed by 64 patients (mean age 54.4 years; 89.1% male). From pre-procedure to the five year follow up there was a consistent increase in the minimum diameter of the TL (13.01 ± 6.52 mm pre-procedure; 23.16 ± 5.37 mm one year follow up; 24.68 ± 5.27 mm five year follow up) and a simultaneous reduction in the maximum diameter of the FL within the bare stent segment (28.69 ± 7.09 mm pre-procedure; 9.08 ± 12.84 mm one year follow up; 7.67 ± 12.51 mm five year follow up). The proportion of patients with complete FL thrombosis in the bare stent segment increased from 64% to 81%. During the five year follow up, three patients developed retrograde type A aortic dissection and three patients underwent a second intervention. CONCLUSION: Following endovascular treatment using the Fabulous system, the five year cTBAD cohort outcomes demonstrated encouraging results regarding TL expansion and FL thrombosis. These results should enhance the understanding of the application of the Proximal ExTension To Induce COmplete ATtachment (PETTICOAT) technique in cTBAD.
引用
- Hu C, Zhang Y, Yang J, et al. Editor's Choice - Five Year Outcomes of the Fabulous Stent System in the Management of Complicated Type B Aortic Dissection: A Prospective Multicentre Study. Eur J Vasc Endovasc Surg. 2025. PMID: 40653301. doi:10.1016/j.ejvs.2025.07.020
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。